Latest mechanical ventilation Stories
Molecular imaging study shows a therapy called adaptive servo-ventilation can improve important nerve function for patients with chronic heart failure Many chronic heart failure patients struggle with not just strenuous activity but even the essentials such as moderate exercise and normal breathing. Research revealed at the Society of Nuclear Medicine’s 2012 Annual Meeting presents an overnight breathing treatment called adaptive servo-ventilation as a potential protocol for energizing...
LONDON, June 11, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today the National Health Service Technology Adoption Centre in the United Kingdom is advising hospitals to use Intraoperative Fluid Management Technologies as a way to improve patient outcomes, and included Masimo's noninvasive and continuous Pleth Variability Index (PVI®) among technologies available for helping clinicians manage fluid during surgeries. "The use of Intraoperative Fluid Management...
WARRINGTON, Pa., June 7, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced it will be presenting neonatal AFECTAIR® data at the 11th European Congress on Pediatric and Neonatal Ventilation being held June 6 - 9, 2012 in Montreux, Switzerland. Though initially presented in the U.S., these data presentations mark the first introduction of the AFECTAIR...
PHILADELPHIA, May 30, 2012 /PRNewswire/ -- New collection is first online, evidence-based skills database designed for respiratory care professionals Elsevier [http://www.clinicaldecisionsupport.com ], the leading provider of scientific, technical and medical information products and services, today announced the availability of a new skills product for respiratory care professionals - Mosby's Respiratory Care Skills...
Gordon D. Rubenfeld, M.D., of the Sunnybrook Health Sciences Center, Toronto, Canada, and colleagues with the ARDS (acute respiratory distress syndrome) Definition Task Force, developed a new definition of ARDS (the Berlin Definition) that focused on feasibility, reliability, validity and objective evaluation of its performance. ARDS is a life-threatening lung condition that prevents enough oxygen from getting to the lungs and into the blood. Among the changes the panel proposed was a...
MUNICH, May 21, 2012 /PRNewswire/ -- SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnea (CSA) improves survival and outcomes of patients with stable heart failure, has enrolled its 1,000th participant. The study, sponsored by ResMed Ltd., is the largest of its kind. This milestone brings the SERVE-HF study, which began in 2008, one step closer to its target of approximately 1,250 participants. Principal investigator Prof. Martin...
WARRINGTON, Pa., May 9, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, reported that data from a preclinical study of SURFAXIN LS(TM) (lyophilized KL(4 )surfactant) was recently published in the May issue of Pediatric Research. The results of the study demonstrate that improvements in lung function following administration of SURFAXIN LS compares favorably to...
WARRINGTON, Pa., May 1, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN(®), when compared with infants treated with Curosurf(®) and Survanta(®), the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants. The...
IRVINE, Calif., April 23, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) , the inventor of rainbow® Pulse CO-Oximetry(TM), rainbow® Acoustic Monitoring(TM), and Masimo SET(®) Measure-Through Motion and Low Perfusion pulse oximetry, today announced that Essential Medical Devices, Inc. dismissed all outstanding claims against Masimo in the patent case it had filed against Masimo and Cercacor. Masimo did not incur any liability to Essential Medical, and the dismissal included a covenant...
IRVINE, Calif., April 19, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that a study published in the current issue of peer-reviewed journal BioScience Trends demonstrates that noninvasive and continuous monitoring of Masimo Pleth Variability Index (PVI®) helps clinicians assess fluid responsiveness during major abdominal surgery and concluded that PVI results were similar to invasive, more expensive stroke volume variation (SVV). Other traditional hemodynamic variables...
